STOCK TITAN

MAIA director buys 133,790 shares at $1.35–$1.39

(Moderate)
(Positive)
Form Type
4

Rhea-AI Filing Summary

MAIA Biotechnology, Inc. (MAIA) director Ramiro Guerrero reported a series of open-market purchases of the company’s common stock. On August 26–28, 2026, he purchased a total of 133,790 shares in three transactions at per-share prices between $1.35 and $1.39, with no sales reported.

Positive

  • None.

Negative

  • None.
Insider Guerrero Ramiro
Role Director
Bought 133,790 shs ($184K)
Type Security Shares Price Value
Purchase Common Stock 46,620 $1.35 $63K
Purchase Common Stock 78,239 $1.39 $109K
Purchase Common Stock 8,931 $1.39 $12K
Holdings After Transaction: Common Stock — 735,701 shares (Direct)
Shares purchased on 2026-08-26 8,931 shares at $1.39 per share Common Stock purchase coded P, direct ownership
Shares purchased on 2026-08-27 78,239 shares at $1.39 per share Common Stock purchase coded P, direct ownership
Shares purchased on 2026-08-28 46,620 shares at $1.35 per share Common Stock purchase coded P, direct ownership
Total shares bought in period 133,790 shares Net buyShares from transaction summary, net-buy direction
open market market
"transaction_code_description: Purchase in open market or private transaction"
An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.
private transaction market
"transaction_code_description: Purchase in open market or private transaction"
A private transaction is the sale or transfer of securities, assets, or ownership stakes carried out directly between a small number of parties rather than on a public exchange. For investors it matters because these deals are less visible and often less liquid than public trades, so pricing can be harder to verify, the investment can be harder to sell quickly, and buyers or sellers may gain strategic advantages not available in open markets — like negotiated terms similar to a private garage sale versus a crowded marketplace.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

What insider transactions did MAIA director Ramiro Guerrero report on this Form 4 for MAIA?

Ramiro Guerrero reported three purchases of MAIA common stock on August 26, 27, and 28, 2026, with no corresponding sales. All transactions were coded as P, indicating purchases in an open market or private transaction.

How many MAIA (MAIA) shares did Ramiro Guerrero buy in total?

Across the three reported transactions, Ramiro Guerrero bought a total of 133,790 shares of MAIA common stock, as summarized in the filing’s transaction summary for net buy/sell shares.

At what prices did Ramiro Guerrero purchase MAIA (MAIA) shares?

Guerrero purchased MAIA common stock at per-share prices of $1.39 on August 26, $1.39 on August 27, and $1.35 on August 28, 2026. Each transaction was identified as a purchase in an open market or private transaction.

Were any MAIA (MAIA) shares sold by Ramiro Guerrero in this Form 4?

No. The Form 4 shows no sales by Ramiro Guerrero. The transaction summary reports buyShares of 133,790 and sellShares of 0, with a net-buy direction.

Were Ramiro Guerrero’s MAIA (MAIA) trades under a Rule 10b5-1 plan?

The filing indicates the Rule 10b5-1 checkbox is not affirmed (the 10b5-1 box is not checked). The transactions are described simply as purchases in open market or private transactions, without plan-based footnote disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Guerrero Ramiro

(Last)(First)(Middle)
444 WEST LAKE STREET, SUITE 1700

(Street)
CHICAGO ILLINOIS 60606

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MAIA Biotechnology, Inc. [ MAIA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/26/2026P8,931A$1.39610,842D
Common Stock08/27/2026P78,239A$1.39689,081D
Common Stock08/28/2026P46,620A$1.35735,701D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Ramiro Guerrero09/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)